The VIP regimen effective treatment to refractory choriocarcinoma: A case report

Chinese Medical Journal (Taipei)

Volumn 59, Issue 5, 1997, Pages 320-324

  Wang, Peng Hui ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Refractory gestational trophoblastic disease; VIP chemotherapy

Indexed keywords

BLEOMYCIN; CISPLATIN; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; MESNA; METHOTREXATE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHORIOCARCINOMA; CLINICAL PROTOCOL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIDRUG RESISTANCE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHORIOCARCINOMA; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; PREGNANCY; UTERINE NEOPLASMS;

EID: 0030877365     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Ober WB, Edgcombe JH, Price EB. The pathology of choriocarcinoma. Ann NY Acad Sci 1971;172:299-326.
2. Newlands ES, Bagshawe KD, Bergent RHJ. Development in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumors (1979-1984). Br J Obstet Gynecol 1986;93:63-9.
3. Sutton GP, Soper JT, Blessing JA. Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease. Am J Obstet Gynecol 1992:167:489-95.
4. Soper JT. Identification and management of high-risk gestational trophoblastic disease. Semin Oncol 1995:22:172-84.
5. Willemse PHB, Aalders JG, Bouma J. Chemotherapy - resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin. Obstet Gynecol 1988:71:438-40.
6. Hammond CB, Weed JC, Currie JL. The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol 1980; 136:844-9.